J Ahonen

Epithelialization in Wound Healing: A Comprehensive Review

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

Chronic Allograft Rejection

Lower-Extremity Peripheral Arterial Disease among Patients with End-Stage Renal Disease

Models for use in wound healing research: A survey focusing on in vitro and in vivo adult soft tissue

Rheumatoid arthritis

Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing

Calcineurin Inhibitor Nephrotoxicity

Rheumatoid arthritis

Body Composition in Renal Transplant Patients

Clinically Significant Drug Interactions with Cyclosporin

SDZ RAD, A NEW RAPAMYCIN DERIVATIVE

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study

Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)

Epidemiology of rheumatoid arthritis in Finland

RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I

Quantitative and reproducible murine model of excisional wound healing

Newer Biological Agents in Rheumatoid Arthritis

Mycophenolate mofetil and its mechanisms of action

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

Rheumatoid arthritis

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II

The value of early intervention in RA—a window of opportunity

The course of established rheumatoid arthritis

Bioelectrical impedance analysis?part I: review of principles and methods

Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1

The Complex Role of Estrogens in Inflammation

A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline

Epidemiology of Peripheral Artery Disease

Wound Healing: A Cellular Perspective

The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years.

Hypercholesterolaemia and vascular disease after transplantation

Mortality in rheumatoid arthritis: 2008 update.

Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis

The effect of donor age on kidney graft function and on histopathological findings.

Peripheral arterial disease as a predictor of outcome after renal transplantation

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: Five‐year experience from the FIN‐RACo trial

Outcome in patients with early rheumatoid arthritis treated according to the “sawtooth” strategy

Peripheral arterial disease as a predictor of outcome after renal transplantation

Granulation tissue formation in viscose cellulose sponges of different design.

Thromboxane-receptor antagonist in renal transplantation.

Lipid profiles with triple drug immunosuppressive therapy and with double drug combinations after renal transplantation and stable graft function.